OTS2025-09-18T17:56:34+00:00Financing the Future of Individualized Medicine: Funding Models for Rare Genetic TherapiesOTS2025-09-18T17:56:34+00:00August 19th, 2025|
OTS2025-09-09T16:11:27+00:00From Discovery to Deals: The Neurological Oligonucleotide Landscape at a GlanceOTS2025-09-09T16:11:27+00:00August 19th, 2025|
OTS2025-09-18T17:59:27+00:00Strategic IP for Oligonucleotide Therapeutics: Maximizing Innovation ValueOTS2025-09-18T17:59:27+00:00July 29th, 2025|
OTS2025-09-18T17:59:48+00:00The importance of involving patients in therapy development; Lessons learned from Duchenne exon skippingOTS2025-09-18T17:59:48+00:00July 29th, 2025|